Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

"PharmaSphere: US Healthcare Policy Update - Impact Analysis of the Affordable Care Act on Stakeholders" Published


Print article Print article
2013-12-13 12:20:15 - Recently published research from GlobalData, "PharmaSphere: US Healthcare Policy Update - Impact Analysis of the Affordable Care Act on Stakeholders", is now available at Fast Market Research

GlobalData's "PharmaSphere: US Healthcare Policy Update - Impact Analysis of the Affordable Care Act on Stakeholders" report provides essential information and analysis on the Affordable Care Act (ACA). GlobalData provides an in-depth analysis of the most significant provisions of the Act, which is expected to alter the landscape of the US healthcare system considerably. The report discusses the timeline of the ACA's provisions as well as the potential impact of these provisions on various stakeholders in the US healthcare system including payers, providers, and pharmaceutical companies. Furthermore, the report analyzes current trends as various stakeholders position themselves to benefit from the ongoing healthcare reform in the US. The report also provides an outlook on what to expect with the full

implementation of the provisions of the ACA.

Throughout the report, GlobalData's analysts provide you with expert insight, expanding on each provision, strategy, and factor discussed, with the aim of providing you with the tools needed for making informed business decisions in a rapidly changing US healthcare system.

Full Report Details at
- www.fastmr.com/prod/752886_pharmasphere_us_healthcare_policy_upd ..

Highlights

Key Questions Answered

* What provisions of the ACA are coming into effect on January 1, 2014?
* What are the implications of the ACA on the payers, providers, pharmaceutical companies, and patients?
* In which therapeutic areas are companies more likely to benefit from the ACA?
* What is the forecast for prescription drug spending in the US through 2021?
* How will pharmacies position themselves to reap the benefits of the ACA's provisions, particularly with the provisions coming into effect in January 2014?
* Are there potential healthcare access issues due to the ACA's provisions?

About the Report

GlobalData's PharmaSphere: US Healthcare Policy Update - Impact Analysis of the Affordable Care Act on Stakeholders report is an essential source of information and analysis on the ACA. GlobalData provides an in-depth analysis of the impact of the ACA on various stakeholders within the US healthcare system, including payers, providers, and pharmaceutical companies. The report discusses key provisions of the Act which are expected to significantly alter the shape of US healthcare. Furthermore, it provides valuable insight on emerging trends as well as potential strategies that are expected to be explored by stakeholders to enable them benefit from these provisions.

Reasons to Get this Report

* The report provides a timeline of the ACA provisions and the potential impact on various stakeholders in the US healthcare system including providers, payers, and pharmaceutical companies
* The report discusses the dynamics of the US pharmaceutical industry including generics, biosimilars, and the Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012
* The report contains expert insights on the strategies being used by these stakeholders to ensure that they benefit significantly from the implementation of the ACA's provisions
* The report includes an outlook on future trends that are expected in the US healthcare system due to impact of the ACA

Partial Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Report Scope
2.2 Upcoming Related Reports
2.3 Recently Published Reports
3 Industry Dynamics
3.1 Soaring Expenditures in the US Healthcare System
3.1.1 US Healthcare Spending and Funding: Following the Healthcare Dollars
3.1.2 Generics: A Cost-Effective Option
3.2 Biosimilars: Proponents and Opponents
3.2.1 State Legislative Tussles
3.3 The Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012
4 US Healthcare Reform
4.1 Overview
4.2 The Individual Mandate Provision
4.2.1 The US Supreme Court Ruling
4.3 Affordable Care Act Implementation Timeline
4.3.1 2010: Provisions Primarily Targeted at Increasing Healthcare Coverage
4.3.2 2011: Additional Rebates for Pharma
4.3.3 2012: The Emergence of Accountable Care Organizations
4.3.4 What's New in 2013?
4.3.5 Beyond 2013 (2014-2018)
5 Stakeholders' Analysis
5.1 Budgetary Impact of Insurance Coverage Provisions in the Affordable Care Act
5.2 Providers
5.2.1 Medicaid Expansion will increase Patient Volume
5.2.2 Looming Healthcare Access Problems?
5.2.3 Potential Increase in Quality of Healthcare Services
5.3 Payers
5.3.1 Increase in Member Volume by Insurance Exchanges
5.3.2 New Taxes and Industry Fees on Health Insurance Payers
5.3.3 Tiered-Provider Networks Continue to Be a Cost-Containment Strategy
5.4 Pharmaceutical Manufacturers
5.4.1 The Affordable Care Act: What's in it for Pharmaceutical Manufacturers?
5.4.2 Prescription Drug Spending Will Grow to over $480 Billion by 2021
6 Strategic Outlook: The Way Forward
6.1 Obamacare Will Get "Rolling" Evaluation
6.2 Significant Shuttling Expected within Health Insurance Plans
6.3 The Pie Gets Even Bigger for Pharmaceutical Companies
6.4 Pharmacies Will Cash-in on Obamacare
7 Appendix
7.1 Bibliography
7.2 Abbreviations
7.3 Research Methodology
7.3.1 Coverage
7.3.2 Secondary Research
7.3.3 Expert Panel Validation
7.4 About the Authors
7.4.1 Analyst
7.4.2 Director of Healthcare Industry Dynamics
7.4.3 Global Director of Epidemiology and Health Policy
7.4.4 Global Head of Healthcare
7.5 About the Industry Dynamics Team
7.6 About GlobalData
7.7 Disclosure Information

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=752886&dt=t

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser